
In their efforts to understand the beneficial effects of SAINT, an important new fast-acting brain stimulation treatment for refractory major...
Read More

Over the last decade, rTMS (repetitive transcranial magnetic stimulation), a form of non-invasive brain stimulation, has become a first-line treatment...
Read More

Depression among people diagnosed with multiple sclerosis (MS) has been estimated to be about three times more common than in...
Read More

Depression that doesn’t respond to conventional treatments is a serious problem for all who are affected, and poses unique risks...
Read More

On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach...
Read More